The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting
Open accessAbstract
Evidence relating to healthcare decisions often comes from more than one study. Decision analytical modelling can be used as a basis for economic evaluations in these situations. Economic evaluations are increasingly conducted alongside randomised controlled trials, providing researchers with individual patient data to estimate cost effectiveness.1 However, randomised trials do not always provide a sufficient basis for economic evaluations used to inform regulatory and reimbursement decisions. For example, a single trial might not compare all the available options, provide evidence on all relevant inputs, or be conducted over a long enough time to capture differences in economic outcomes (or even measure those outcomes).2 In addition, reliance on a single trial may mean ignoring evidence from other trials, meta-analyses, and observational studies. Under these circumstances, decision analytical modelling provides an alternative framework for economic evaluation. Decision analytical modelling compares the expected costs and consequences of decision options by synthesising information from multiple sources and applying mathematical techniques, usually with computer software. The aim is to provide decision makers with the best available evidence to reach a decision—for example, should a new drug be adopted? Following on from our article on trial based economic evaluations,1 we outline issues relating to the design, conduct, analysis, and reporting of economic evaluations using decision analytical modelling. #### Glossary of terms
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Decision Modelling For Health Economic Evaluation
Briggs, A., Claxton, K., & Sculpher, M. (2006) · doi:10.1093/oso/9780198526629.001.0001 · Cited by 3,153
Weinstein, M. C., O'Brien, B., Hornberger, J., Jackson, J., Johannesson, M., McCabe, C., & Luce, B. R. (2003) · Value in Health · doi:10.1046/j.1524-4733.2003.00234.x · Cited by 1,172
Methods for the economic evaluation of health care programmes, 3rd ed
Adamiak, G. T. (2006) · PubMed Central · Cited by 953
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Subgroup analysis in randomised controlled trials: importance, indications, and interpretation
Rothwell, P. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17709-5 · Cited by 942
Utilities and Quality-Adjusted Life Years
Torrance, G. W., & Feeny, D. (1989) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008461 · Cited by 818
Philips, Z., Ginnelly, L., Sculpher, M., Claxton, K., Golder, S., Riemsma, R., Woolacoot, N., & Glanville, J. (2004) · Health Technology Assessment · doi:10.3310/hta8360 · Cited by 697
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615
Self-citationA taxonomy of model structures for economic evaluation of health technologies
Brennan, A., Chick, S. E., & Davies, R. (2006) · Health Economics · doi:10.1002/hec.1148 · Cited by 555
Philips, Z., Bojke, L., Sculpher, M., Claxton, K., & Golder, S. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624040-00006 · Cited by 502
Wu, O., Robertson, L., Twaddle, S., Lowe, G., Clark, P., Greaves, M., Walker, I., Langhorne, P., Brenkel, I., Regan, L., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10110 · Cited by 489
A systematic review of the role of bisphosphonates in metastatic disease
Ross, J., Saunders, Y., Edmonds, P., Patel, S., Wonderling, D., Normand, C., & Broadley, K. (2004) · Health Technology Assessment · doi:10.3310/hta8040 · Cited by 467
Whither trial‐based economic evaluation for health care decision making?
Sculpher, M. J., Claxton, K., Drummond, M., & McCabe, C. (2006) · Health Economics · doi:10.1002/hec.1093 · Cited by 407
Applied Methods of Cost-effectiveness Analysis in HealthcarePreprint
Gray, A. M., Clarke, P., Wolstenholme, J. L., & Wordsworth, S. (2010) · RePEc: Research Papers in Economics · Cited by 343
Self-citationEconomic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting
Petrou, S., & Gray, A. (2011) · BMJ · doi:10.1136/bmj.d1548 · Cited by 318
Self-citationWiggins, M., Oakley, A., Roberts, I., Turner, H., Rajan, L., Austerberry, H., Mujica, R., & Mugford, M. (2004) · Health Technology Assessment · doi:10.3310/hta8320 · Cited by 296
Modelling in the economic evaluation of health care: selecting the appropriate approach
Barton, P., Bryan, S., & Robinson, S. (2004) · Journal of Health Services Research & Policy · doi:10.1258/135581904322987535 · Cited by 291
Claxton, K., Ginnelly, L., Sculpher, M., Philips, Z., & Palmer, S. (2004) · Health Technology Assessment · doi:10.3310/hta8310 · Cited by 258
Drummond, M., Manca, A., & Sculpher, M. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050221 · Cited by 251
Economic Evaluation of Vaccination Programs: The Impact of Herd-Immunity
Brisson, M., & Edmunds, W. J. (2003) · Medical Decision Making · doi:10.1177/0272989x02239651 · Cited by 251
Recent developments in decision-analytic modelling for economic evaluation
Weinstein, M. C. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624110-00002 · Cited by 220
The cost-effectiveness of screening for oral cancer in primary care
Speight, P., Palmer, S., Moles, D., Downer, M., Smith, D., Henriksson, M., & Augustovski, F. (2006) · Health Technology Assessment · doi:10.3310/hta10140 · Cited by 210
Nelson, E., O'Meara, S., Craig, D., Iglesias, C., Golder, S., Dalton, J., Claxton, K., Bell-Syer, S., Jude, E., Dowson, C., et al. (2006) · Health Technology Assessment · doi:10.3310/hta10120 · Cited by 201
Computer Modeling of Diabetes and Its Complications
The Mount Hood 4 Modeling Group (2007) · Diabetes Care · doi:10.2337/dc07-9919 · Cited by 199
Bojke, L., Claxton, K., Sculpher, M., & Palmer, S. (2009) · Value in Health · doi:10.1111/j.1524-4733.2008.00502.x · Cited by 184
Multiparameter Evidence Synthesis in Epidemiology and Medical Decision-Making: Current Approaches
Ades, A. E., & Sutton, A. J. (2006) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2005.00377.x · Cited by 159
Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines
Stout, N. K., Knudsen, A. B., Kong, C. Y., McMahon, P. M., & Gazelle, G. S. (2009) · PharmacoEconomics · doi:10.2165/11314830-000000000-00000 · Cited by 129
Collaborative, H. P. S. (2006) · BMJ · doi:10.1136/bmj.38993.731725.be · Cited by 110
Ades, A. E., & Cliffe, S. (2002) · Medical Decision Making · doi:10.1177/027298902400448920 · Cited by 104
Choice of modelling technique for evaluating health care interventions
Cooper, K., Brailsford, S., & Davies, R. J. (2006) · Journal of the Operational Research Society · doi:10.1057/palgrave.jors.2602230 · Cited by 87
The Half-Life of Truth: What Are Appropriate Time Horizons for Research Decisions?
Philips, Z., Claxton, K., & Palmer, S. (2008) · Medical Decision Making · doi:10.1177/0272989x07312724 · Cited by 79
The cost-effectiveness of testing for hepatitis C in former injecting drug users
Castelnuovo, E., Coon, J. T., Pitt, M., Cramp, M., Siebert, U., Price, A., & Stein, K. (2006) · Health Technology Assessment · doi:10.3310/hta10320 · Cited by 73
Legood, R., Gray, A., Wolstenholme, J., & Moss, S. (2006) · BMJ · doi:10.1136/bmj.38698.458866.7c · Cited by 68
Self-citationThe Problem of Protocol Driven Costs in Pharmacoeconomic Analysis
Coyle, D., & Lee, K. M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814040-00003 · Cited by 42
Bojke, L., Hornby, E., & Sculpher, M. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725100-00003 · Cited by 33
Cited by
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Self-citationConsolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Self-citationHusereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.11.1351 · Cited by 1,095
Self-citationA catalogue of reporting guidelines for health research
Simera, I., Moher, D., Hoey, J., Schulz, K. F., & Altman, D. G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02234.x · Cited by 1,047
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., et al. (2022) · Value in Health · doi:10.1016/j.jval.2021.10.008 · Cited by 847
Self-citation
Metadata
- Authors
- Petrou, S., & Gray, A.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2011-04-11
- Volume
- 342
- Issue
- apr11 1
- Pages
- d1766-d1766
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2104471448
- Cited by
- 292
- References
- 37
- FWCI
- 45.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.